Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yee

Showing results (221-230 of 506) with videos related to

Pageof 51
Sort By:
Rheumatology (Oxford, England)|February 22, 2003
Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosusC-S Yee, H Hussein, J Skan, et al.
Cell Death and Differentiation|March 21, 2009
PUMA- and Bax-induced autophagy contributes to apoptosisK S Yee, S Wilkinson, J James, et al.
Journal of Clinical Psychopharmacology|January 12, 2022
Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders: A Systematic Review and Network Meta-AnalysisCaitlin S Yee, Anees Bahji, Maria Lolich, et al.
Frontiers in Immunology|June 3, 2024
Commentary: Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysisIna Zhang, Jeroen P Jansen, Benjamin J Yungher, et al.
International Journal of Food Microbiology|May 10, 2002
Spectral surface plasmon resonance biosensor for detection of staphylococcal enterotoxin B in milkJirí Homola, Jakub Dostálek, Shengfu Chen, et al.
Annals of Human Genetics|January 1, 1976
Population structure of Barra (Outer Hebrides)N E Morton, C Smith, R Hill, et al.
Journal of Health Economics and Outcomes Research|September 28, 2022
Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart ReviewKaren S Yee, David Alexanderian, Yidie Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factorC C Taylor, D Wu, Y Soong, et al.
Clinical Rheumatology|January 8, 2015
The efficacy and safety of rituximab in a chart review study of 15 patients with systemic lupus erythematosusR A Hickman, R Hira-Kazal, C-S Yee, et al.
Neuroendocrinology|December 1, 1996
Differential mechanisms of ovine fetal pituitary stimulation by a selective kappa-opioid agonist and by dynorphinC C Taylor, D WU, Y Soong, et al.
Pageof 51

Showing results (221-230 of 506) with videos related to

Sort By:
Pageof 51
Rheumatology (Oxford, England)|February 22, 2003
Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosusC-S Yee, H Hussein, J Skan, et al.
Cell Death and Differentiation|March 21, 2009
PUMA- and Bax-induced autophagy contributes to apoptosisK S Yee, S Wilkinson, J James, et al.
Journal of Clinical Psychopharmacology|January 12, 2022
Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders: A Systematic Review and Network Meta-AnalysisCaitlin S Yee, Anees Bahji, Maria Lolich, et al.
Frontiers in Immunology|June 3, 2024
Commentary: Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysisIna Zhang, Jeroen P Jansen, Benjamin J Yungher, et al.
International Journal of Food Microbiology|May 10, 2002
Spectral surface plasmon resonance biosensor for detection of staphylococcal enterotoxin B in milkJirí Homola, Jakub Dostálek, Shengfu Chen, et al.
Annals of Human Genetics|January 1, 1976
Population structure of Barra (Outer Hebrides)N E Morton, C Smith, R Hill, et al.
Journal of Health Economics and Outcomes Research|September 28, 2022
Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart ReviewKaren S Yee, David Alexanderian, Yidie Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factorC C Taylor, D Wu, Y Soong, et al.
Clinical Rheumatology|January 8, 2015
The efficacy and safety of rituximab in a chart review study of 15 patients with systemic lupus erythematosusR A Hickman, R Hira-Kazal, C-S Yee, et al.
Neuroendocrinology|December 1, 1996
Differential mechanisms of ovine fetal pituitary stimulation by a selective kappa-opioid agonist and by dynorphinC C Taylor, D WU, Y Soong, et al.
Pageof 51